Medical Condition News

RSS

CardioFocus completes HeartLight EAS pivotal trial enrollment for symptomatic paroxysmal AF

CardioFocus, Inc., developer of the HeartLight Endoscopic Ablation System for the treatment of atrial fibrillation, today announced that it has concluded enrollment of its U.S. pivotal trial evaluating the HeartLight system, for the treatment of symptomatic paroxysmal AF.

17 Oct 2013

Liverpool Care Pathway provides little clinical benefit for dying cancer patients

The first randomised trial to test the effectiveness of the Liverpool Care Pathway (LCP) programme, developed and implemented widely to support patients as they near death, has found little clinical benefit compared with standard care for cancer patients dying in hospital.

17 Oct 2013

Thyroid specialists recommend thyroid function testing for pregnant women

Decreased thyroid function can have a detrimental effect on pregnancy outcomes. A majority of thyroid specialists surveyed recommend thyroid function testing for all pregnant women. The results of a survey conducted at the 2012 annual meeting of the American Thyroid Association will be delivered in a poster to be presented at the upcoming 83rd Annual Meeting of the ATA, October 16-20, 2013, in San Juan, Puerto Rico.

17 Oct 2013

Researchers use technology to help immobilized stroke survivors regain some independence

A team of researchers from Montreal has found that stroke patients living with Locked-In Syndrome (LIS) who cannot move, swallow or even breathe on their own, can regain a remarkable level of independence with technological help.

17 Oct 2013

Study focuses on vaccine-preventable illnesses in myasthenia gravis patients

A study presented at the annual meeting of the American Association of Neuromuscular & Electrodiagnostic Medicine is considered a good first step in collecting data on vaccine-preventable illnesses in patients with myasthenia gravis, a neuromuscular disorder causing weakness and rapid fatigue of voluntary muscles.

17 Oct 2013

Researchers find 5-fold increase in high cholesterol risk

What leads to high cholesterol? Your genes and lifestyle factors may not explain it all. A study presented today at the Canadian Cardiovascular Congress has connected some of the risk for high cholesterol in adults to their mother's cholesterol levels before she even became pregnant.

17 Oct 2013

Nintedanib drug to treat NSCLC is submitted for approval from European Medicines Agency

Boehringer Ingelheim announced the submission of a Marketing Authorisation Application to the European Medicines Agency for the approval of its oral triple angiokinase inhibitor nintedanib, in combination with docetaxel, for the treatment of patients with locally advanced, metastatic or recurrent non-small cell lung cancer (NSCLC) of adenocarcinoma tumour histology after first line chemotherapy.

17 Oct 2013

BRAF inhibitor vemurafenib effective for patients with papillary thyroid cancer

Mutations in a gene that codes for the enzyme BRAF kinase have been associated with increased risk for papillary thyroid cancer. An early-stage clinical trial of the BRAF inhibitor vemurafenib resulted in either a partial response or stable disease in patients with PTC and BRAF mutations.

17 Oct 2013

Study explores advantages of minimally invasive parathyroidectomy for treating hyperparathyroidism

An open surgical procedure called bilateral neck exploration has been the gold standard operation for treating patients with primary hyperparathyroidism. But the development of a minimally invasive procedure to remove the parathyroid gland now offers a new option.

17 Oct 2013

Elderly people with hardening of arteries are more likely to have beta-amyloid plaques in brain

Even for elderly people with no signs of dementia, those with hardening of the arteries are more likely to also have the beta-amyloid plaques in the brain that are a hallmark of Alzheimer's disease, according to a study published in the October 16, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology.

17 Oct 2013

Researchers find novel drug target for anaplastic thyroid carcinomas

Anaplastic thyroid carcinomas are aggressive tumors that do not respond to traditional radio- or chemotherapeutic agents, and there currently is no cure or effective treatment available. Median survival from diagnosis is 5 months, and although ATC accounts for only 1.7% of all thyroid cancers in the U.S., it is responsible for a large proportion of thyroid cancer-related deaths.

17 Oct 2013

Scientists uncover faulty brain mechanism that may underlie schizophrenia in humans

Working with mice genetically engineered to display symptoms of schizophrenia, neuroscientists at the RIKEN-MIT Center for Neural Circuit Genetics at the Picower Institute for Learning and Memory at MIT have uncovered a faulty brain mechanism that may underlie schizophrenia and other psychiatric disorders in humans.

17 Oct 2013

Scientists identify 127 mutated genes that appear to drive development of tumors in the body

Examining 12 major types of cancer, scientists at Washington University School of Medicine in St. Louis have identified 127 repeatedly mutated genes that appear to drive the development and progression of a range of tumors in the body. The discovery sets the stage for devising new diagnostic tools and more personalized cancer treatments.

17 Oct 2013

Researchers discover why women with BRCA gene develop breast and ovarian cancer

Researchers announced today in the journal Lancet Oncology that they are well on the way to discovering why women with the faulty genes BRCA 1 and BRCA 2, one of which was inherited by the actress Angelina Jolie, develop breast and ovarian cancer rather than other cancers.

17 Oct 2013

Babies born to teen mothers have underdeveloped speaking skills, says study

Babies born to teen mothers have less developed speaking skills at age five than children of older mothers, a new study has found.

17 Oct 2013

Researchers develop new tool to quantify myocardial damage in heart attack patients

Researchers from the Computer Vision Center (CVC) have developed a new tool to quantify the myocardial perfusion damage in people who had a heart attack or an angina. Having been validated in 200 patients, it can help improve and speed up diagnosis of the damage, offering a quantitative, repeatable and objective measure of the blood irrigation level of the heart tissue.

17 Oct 2013

New England publishes results of phase III clinical trial of ABRAXANE for metastatic pancreatic cancer

Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation , today announced the results of the MPACT phase III clinical trial of ABRAXANE® in combination with gemcitabine were published online in the October 16th edition of the New England Journal of Medicine.

17 Oct 2013

Researchers develop simple blood test to identify patient with Irritable Bowel Syndrome

For the first time, a simple blood test may be the best way to determine if a patient is suffering from Irritable Bowel Syndrome, or another serious condition such as Inflammatory Bowel Disease, according to Cedars-Sinai physician researcher Mark Pimentel, MD, lead author of a multicenter clinical trial.

17 Oct 2013

Study shows treatment for hypothyroidism is not associated with weight loss in most people

Decreased thyroid function, or hypothyroidism, is commonly associated with weight gain. But contrary to popular belief, effective treatment with levothyroxine (LT4) to restore normal thyroid hormone levels is not associated with clinically significant weight loss in most people.

17 Oct 2013

Simple urine test uses nanotechnology to detect dangerous blood clotting

Life-threatening blood clots can form in anyone who sits on a plane for a long time, is confined to bed while recovering from surgery, or takes certain medications.

17 Oct 2013

Medical Condition News

CardioFocus completes HeartLight EAS pivotal trial enrollment for symptomatic paroxysmal AF

Liverpool Care Pathway provides little clinical benefit for dying cancer patients

Thyroid specialists recommend thyroid function testing for pregnant women

Researchers use technology to help immobilized stroke survivors regain some independence

Study focuses on vaccine-preventable illnesses in myasthenia gravis patients

Researchers find 5-fold increase in high cholesterol risk

Nintedanib drug to treat NSCLC is submitted for approval from European Medicines Agency

BRAF inhibitor vemurafenib effective for patients with papillary thyroid cancer

Study explores advantages of minimally invasive parathyroidectomy for treating hyperparathyroidism

Elderly people with hardening of arteries are more likely to have beta-amyloid plaques in brain

Researchers find novel drug target for anaplastic thyroid carcinomas

Scientists uncover faulty brain mechanism that may underlie schizophrenia in humans

Scientists identify 127 mutated genes that appear to drive development of tumors in the body

Researchers discover why women with BRCA gene develop breast and ovarian cancer

Babies born to teen mothers have underdeveloped speaking skills, says study

Researchers develop new tool to quantify myocardial damage in heart attack patients

New England publishes results of phase III clinical trial of ABRAXANE for metastatic pancreatic cancer

Researchers develop simple blood test to identify patient with Irritable Bowel Syndrome

Study shows treatment for hypothyroidism is not associated with weight loss in most people

Simple urine test uses nanotechnology to detect dangerous blood clotting

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

Latest News